Okamoto Ikumi, Tonkin-Crine Sarah, Rayner Hugh, Murtagh Fliss E M, Farrington Ken, Caskey Fergus, Tomson Charles, Loud Fiona, Greenwood Roger, O'Donoghue Donal J, Roderick Paul
Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;
Department of Renal Medicine, Heart of England NHS Foundation Trust, Birmingham, United Kingdom;
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):120-6. doi: 10.2215/CJN.05000514. Epub 2014 Nov 11.
Conservative kidney management (CKM) has been developed in the United Kingdom (UK) as an alternative to dialysis for older patients with stage 5 CKD (CKD5) and multiple comorbidities. This national survey sought to describe the current scale and pattern of delivery of conservative care in UK renal units and identify their priorities for its future development.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A survey on practice patterns of CKM for patients age 75 and older with CKD5 was sent to clinical directors of all 71 adult renal units in the UK in March 2013.
Sixty-seven units (94%) responded. All but one unit reported providing CKM for some patients. Terminology varied, although "conservative management" was the most frequently used term (46%). Lack of an agreed-upon definition of when a patient is receiving CKM made it difficult to obtain meaningful data on the numbers of such patients. Fifty-two percent provided the number of CKM patients age ≥ 75 years in 2012; the median was 45 per unit (interquartile range [IQR], 20-83). The median number of symptomatic CKM patients who would otherwise have started dialysis was eight (IQR, 4.5-22). CKM practice patterns varied: 35% had a written guideline, 23% had dedicated CKM clinics, 45% had dedicated staff, and 50% provided staff training on CKM. Most units (88%) provided primary care clinicians with information/advice regarding CKM. Eighty percent identified a need for better evidence comparing outcomes on CKM versus dialysis, and 65% considered it appropriate to enter patients into a randomized trial.
CKM is provided in almost all UK renal units, but scale and organization vary widely. Lack of common terminology and definitions hinders the development and assessment of CKM. Many survey respondents expressed support for further research comparing outcomes with conservative care versus dialysis.
在英国,保守肾脏管理(CKM)已被开发出来,作为患有5期慢性肾脏病(CKD5)及多种合并症的老年患者的透析替代方案。这项全国性调查旨在描述英国肾脏单位当前保守治疗的实施规模和模式,并确定其未来发展的优先事项。
设计、地点、参与者及测量方法:2013年3月,一项针对75岁及以上CKD5患者的CKM实践模式调查被发送给英国所有71个成人肾脏单位的临床主任。
67个单位(94%)做出了回应。除一个单位外,所有单位都报告为一些患者提供了CKM。术语各不相同,尽管“保守管理”是最常用的术语(46%)。由于缺乏关于患者何时接受CKM的商定定义,难以获得此类患者数量的有意义数据。52%的单位提供了2012年75岁及以上CKM患者的数量;中位数为每个单位45名(四分位间距[IQR],20 - 83)。原本会开始透析的有症状CKM患者的中位数为8名(IQR,4.5 - 22)。CKM的实践模式各不相同:35%有书面指南,23%有专门的CKM诊所,45%有专门的工作人员,50%提供关于CKM的工作人员培训。大多数单位(88%)向初级保健临床医生提供有关CKM的信息/建议。80%的单位认为需要更好的证据来比较CKM与透析的结果,65%的单位认为将患者纳入随机试验是合适的。
几乎所有英国肾脏单位都提供CKM,但规模和组织差异很大。缺乏通用术语和定义阻碍了CKM的发展和评估。许多调查受访者表示支持进一步研究比较保守治疗与透析的结果。